Our data demonstrates that Aβ1–42 is significantly lower in FXS plasma than control subjects, and in conjunction with two studies demonstrating elevated sAβPPα in autistic children [16], [17], suggests that both AβPP and Aβ are viable biomarkers for FXS. Here, APP is linked to fragile X syndrome.